BCAX
Bicara Therapeutics Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Bicara Therapeutics (BCAX) Stock: Buy, Sell, or Hold?
$10.18
+0.20 (+2.00%)
▲
5d:
+13.62%
30d:
-41.26%
90d:
-58.67%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
48/100
Position
OVERSOLD
30-Day Fair Range
$10.44 – $18.36
Position: OVERSOLD
Forward P/E & Valuation
-2.8x
Next 12M consensus est.
Wall Street Target
$33.92
+233.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$7.87 / $17.57
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: BCAX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When BCAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BCAX is currently trading at $10.18, which is considered oversold relative to its 30-day fair value range of $10.44 to $18.36.
Technical Outlook: Technically, BCAX is in a strong downtrend. Immediate support is located at $7.87, while resistance sits at $17.57.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.92 (+233.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BCAX is in a strong downtrend. Immediate support is located at $7.87, while resistance sits at $17.57.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.92 (+233.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$10.44 -
$18.36
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$10.44 -
$18.36
Current vs Trading Range
OVERSOLD
Support Level
$7.87
Resistance Level
$17.57
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 233.2% below Wall St target ($33.92)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.78
Wall Street Target
$33.92
(+233.2%)
Share BCAX Analysis
Share this live BCAX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BCAX)
Bearish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
Bearish sentiment prevails on StockTwits with one user predicting $BCAX to close at $7 by EOD.
Key Retail Themes:
Bearish price prediction
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:58 AM ET
Data refreshes hourly during market hours. Next update: 9:58 AM
Data refreshes hourly during market hours. Next update: 9:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 47 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 63 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BCAX Research Pages
